|
|
Coronavirus disease 2019 (COVID-19): a clinical update |
Min Zhou1,2,3, Xinxin Zhang1,4, Jieming Qu1,2,3() |
1. National Research Center for Translational Medicine, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China 2. Department of Respiratory and Critical Care Medicine, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China 3. Institute of Respiratory Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China 4. Research Laboratory of Clinical Virology, Ruijin Hospital and Ruijin Hospital North Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China |
|
|
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has posed a significant threat to global health. It caused a total of 80 868 confirmed cases and 3101 deaths in Chinese mainland until March 8, 2020. This novel virus spread mainly through respiratory droplets and close contact. As disease progressed, a series of complications tend to develop, especially in critically ill patients. Pathological findings showed representative features of acute respiratory distress syndrome and involvement of multiple organs. Apart from supportive care, no specific treatment has been established for COVID-19. The efficacy of some promising antivirals, convalescent plasma transfusion, and tocilizumab needs to be investigated by ongoing clinical trials.
|
Keywords
coronavirus disease 2019
epidemiology
pathology
radiology
clinical characteristics
treatment
|
Corresponding Author(s):
Jieming Qu
|
Just Accepted Date: 13 March 2020
Online First Date: 02 April 2020
Issue Date: 09 May 2020
|
|
1 |
Z Wu, JM McGoogan. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020 Feb 24. [Epub ahead of print] doi: 10.1001/jama.2020.2648
https://doi.org/10.1001/jama.2020.2648
pmid: 32091533
|
2 |
Q Li, X Guan, P Wu, X Wang, L Zhou, Y Tong, R Ren, KSM Leung, EHY Lau, JY Wong, X Xing, N Xiang, Y Wu, C Li, Q Chen, D Li, T Liu, J Zhao, M Liu, W Tu, C Chen, L Jin, R Yang, Q Wang, S Zhou, R Wang, H Liu, Y Luo, Y Liu, G Shao, H Li, Z Tao, Y Yang, Z Deng, B Liu, Z Ma, Y Zhang, G Shi, TTY Lam, JTK Wu, GF Gao, BJ Cowling, B Yang, GM Leung, Z Feng. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020 Jan 29. [Epub ahead of print] doi: 10.1056/NEJMoa2001316
https://doi.org/10.1056/NEJMoa2001316
pmid: 31995857
|
3 |
H Wang, Z Wang, Y Dong, R Chang, C Xu, X Yu, S Zhang, L Tsamlag, M Shang, J Huang, Y Wang, G Xu, T Shen, X Zhang, Y Cai. Phase-adjusted estimation of the number of coronavirus disease 2019 cases in Wuhan, China. Cell Discov 2020; 6(1): 10
https://doi.org/10.1038/s41421-020-0148-0
pmid: 32133152
|
4 |
N Chen, M Zhou, X Dong, J Qu, F Gong, Y Han, Y Qiu, J Wang, Y Liu, Y Wei, J Xia, T Yu, X Zhang, L Zhang. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395(10223): 507–513
https://doi.org/10.1016/S0140-6736(20)30211-7
pmid: 32007143
|
5 |
JF Chan, S Yuan, KH Kok, KK To, H Chu, J Yang, F Xing, J Liu, CC Yip, RW Poon, HW Tsoi, SK Lo, KH Chan, VK Poon, WM Chan, JD Ip, JP Cai, VC Cheng, H Chen, CK Hui, KY Yuen. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020; 395(10223): 514–523
https://doi.org/10.1016/S0140-6736(20)30154-9
pmid: 31986261
|
6 |
R Huang, J Xia, Y Chen, C Shan, C Wu. A family cluster of SARS-CoV-2 infection involving 11 patients in Nanjing, China. Lancet Infect Dis 2020 Feb 28. [Epub ahead of print] doi: 10.1016/S1473-3099(20)30147-X
https://doi.org/10.1016/S1473-3099(20)30147-X
pmid: 32119823
|
7 |
W Zhang, RH Du, B Li, XS Zheng, XL Yang, B Hu, YY Wang, GF Xiao, B Yan, ZL Shi, P Zhou. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect 2020; 9(1): 386–389
https://doi.org/10.1080/22221751.2020.1729071
pmid: 32065057
|
8 |
SWX Ong, YK Tan, PY Chia, TH Lee, OT Ng, MSY Wong, K Marimuthu. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA 2020 Mar 4. [Epub ahead of print] doi: 10.1001/jama.2020.3227
https://doi.org/10.1001/jama.2020.3227
pmid: 32129805
|
9 |
N Zhu, D Zhang, W Wang, X Li, B Yang, J Song, X Zhao, B Huang, W Shi, R Lu, P Niu, F Zhan, X Ma, D Wang, W Xu, G Wu, GF Gao, W Tan; China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382(8): 727–733
https://doi.org/10.1056/NEJMoa2001017
pmid: 31978945
|
10 |
S Su, G Wong, W Shi, J Liu, ACK Lai, J Zhou, W Liu, Y Bi, GF Gao. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol 2016; 24(6): 490–502
https://doi.org/10.1016/j.tim.2016.03.003
pmid: 27012512
|
11 |
D Forni, R Cagliani, M Clerici, M Sironi. Molecular evolution of human coronavirus genomes. Trends Microbiol 2017; 25(1): 35–48
https://doi.org/10.1016/j.tim.2016.09.001
pmid: 27743750
|
12 |
R Lu, X Zhao, J Li, P Niu, B Yang, H Wu, W Wang, H Song, B Huang, N Zhu, Y Bi, X Ma, F Zhan, L Wang, T Hu, H Zhou, Z Hu, W Zhou, L Zhao, J Chen, Y Meng, J Wang, Y Lin, J Yuan, Z Xie, J Ma, WJ Liu, D Wang, W Xu, EC Holmes, GF Gao, G Wu, W Chen, W Shi, W Tan. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020; 395(10224): 565–574
https://doi.org/10.1016/S0140-6736(20)30251-8
pmid: 32007145
|
13 |
D Wrapp, N Wang, KS Corbett, JA Goldsmith, CL Hsieh, O Abiona, BS Graham, JS McLellan. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 2020 Feb 19. [Epub ahead of print] doi: 10.1126/science.abb2507
https://doi.org/10.1126/science.abb2507
pmid: 32075877
|
14 |
X Xu, P Chen, J Wang, J Feng, H Zhou, X Li, W Zhong, P Hao. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci 2020; 63(3): 457–460
https://doi.org/10.1007/s11427-020-1637-5
pmid: 32009228
|
15 |
P Zhou, XL Yang, XG Wang, B Hu, L Zhang, W Zhang, HR Si, Y Zhu, B Li, CL Huang, HD Chen, J Chen, Y Luo, H Guo, RD Jiang, MQ Liu, Y Chen, XR Shen, X Wang, XS Zheng, K Zhao, QJ Chen, F Deng, LL Liu, B Yan, FX Zhan, YY Wang, GF Xiao, ZL Shi. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579(7798): 270–273
https://doi.org/10.1038/s41586-020-2012-7
|
16 |
E de Wit, N van Doremalen, D Falzarano, VJ Munster. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol 2016; 14(8): 523–534
https://doi.org/10.1038/nrmicro.2016.81
pmid: 27344959
|
17 |
National Health Commission of the People’s Republic of China. Guideline for the diagnosis and treatment of COVID-19 infections (version 1–7). 2020.
|
18 |
XW Xu, XX Wu, XG Jiang, KJ Xu, LJ Ying, CL Ma, SB Li, HY Wang, S Zhang, HN Gao, JF Sheng, HL Cai, YQ Qiu, LJ Li. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ 2020; 368: m606
https://doi.org/10.1136/bmj.m606
pmid: 32075786
|
19 |
JJ Zhang, X Dong, YY Cao, YD Yuan, YB Yang, YQ Yan, CA Akdis, YD Gao. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020 Feb 19. [Epub ahead of print] doi: 10.1111/all.14238
https://doi.org/10.1111/all.14238
pmid: 32077115
|
20 |
X Yang, Y Yu, J Xu, H Shu, J Xia, H Liu, Y Wu, L Zhang, Z Yu, M Fang, T Yu, Y Wang, S Pan, X Zou, S Yuan, Y Shang. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020 Feb 24. [Epub ahead of print] doi: 10.1016/S2213-2600(20)30079-5
https://doi.org/10.1016/S2213-2600(20)30079-5
pmid: 32105632
|
21 |
WJ Guan, ZY Ni, Y Hu, WH Liang, CQ Ou, JX He, L Liu, H Shan, CL Lei, DSC Hui, B Du, LJ Li, G Zeng, KY Yuen, RC Chen, CL Tang, T Wang, PY Chen, J Xiang, SY Li, JL Wang, ZJ Liang, YX Peng, L Wei, Y Liu, YH Hu, P Peng, JM Wang, JY Liu, Z Chen, G Li, ZJ Zheng, SQ Qiu, J Luo, CJ Ye, SY Zhu, NS Zhong; China Medical Treatment Expert Group for COVID-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020 Feb 28. [Epub ahead of print] doi: 10.1056/NEJMoa2002032
https://doi.org/10.1056/NEJMoa2002032
pmid: 32109013
|
22 |
C Huang, Y Wang, X Li, L Ren, J Zhao, Y Hu, L Zhang, G Fan, J Xu, X Gu, Z Cheng, T Yu, J Xia, Y Wei, W Wu, X Xie, W Yin, H Li, M Liu, Y Xiao, H Gao, L Guo, J Xie, G Wang, R Jiang, Z Gao, Q Jin, J Wang, B Cao. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395(10223): 497–506
https://doi.org/10.1016/S0140-6736(20)30183-5
pmid: 31986264
|
23 |
D Wang, B Hu, C Hu, F Zhu, X Liu, J Zhang, B Wang, H Xiang, Z Cheng, Y Xiong, Y Zhao, Y Li, X Wang, Z Peng. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020 Feb 7. [Epub ahead of print] doi: 10.1001/jama.2020.1585
https://doi.org/10.1001/jama.2020.1585
pmid: 32031570
|
24 |
WHO. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance. 2020.
|
25 |
SV Konstantinides, G Meyer, C Becattini, H Bueno, GJ Geersing, VP Harjola, MV Huisman, M Humbert, CS Jennings, D Jiménez, N Kucher, IM Lang, M Lankeit, R Lorusso, L Mazzolai, N Meneveau, F Ní Áinle, P Prandoni, P Pruszczyk, M Righini, A Torbicki, E Van Belle, JL Zamorano; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 2020; 41(4): 543–603
https://doi.org/10.1093/eurheartj/ehz405
pmid: 31504429
|
26 |
S Tian, W Hu, L Niu, H Liu, H Xu, SY Xiao. Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol 2020 Feb 27. [Epub ahead of print] doi: 10.1016/j.jtho.2020.02.010
https://doi.org/10.1016/j.jtho.2020.02.010
pmid: 32114094
|
27 |
Z Xu, L Shi, Y Wang, J Zhang, L Huang, C Zhang, S Liu, P Zhao, H Liu, L Zhu, Y Tai, C Bai, T Gao, J Song, P Xia, J Dong, J Zhao, FS Wang. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020 Feb 18. [Epub ahead of print] doi: 10.1016/S2213-2600(20)30076-X.
https://doi.org/10.1016/S2213-2600(20)30076-X
pmid: 32085846
|
28 |
W, Luo H, Yu J, Gou X, Li Y, Sun J, Li L. LiuClinical pathology of critical patient with novel coronavirus pneumonia (COVID-19). Preprints 2020; 2020020407
|
29 |
H Shi, X Han, N Jiang, Y Cao, O Alwalid, J Gu, Y Fan, C Zheng. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis 2020 Feb 24. [Epub ahead of print] doi: 10.1016/S1473-3099(20)30086-4
https://doi.org/10.1016/S1473-3099(20)30086-4
pmid: 32105637
|
30 |
W Zhao, Z Zhong, X Xie, Q Yu, J Liu. Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study. AJR Am J Roentgenol 2020 Mar 3. [Epub ahead of print] doi: 10.2214/AJR.20.22976
https://doi.org/10.2214/AJR.20.22976
pmid: 32125873
|
31 |
HJ Koo, S Lim, J Choe, SH Choi, H Sung, KH Do. Radiographic and CT features of viral pneumonia. Radiographics 2018; 38(3): 719–739
https://doi.org/10.1148/rg.2018170048
pmid: 29757717
|
32 |
T Franquet, NL Müller, A Giménez, S Martínez, M Madrid, P Domingo. Infectious pulmonary nodules in immunocompromised patients: usefulness of computed tomography in predicting their etiology. J Comput Assist Tomogr 2003; 27(4): 461–468
https://doi.org/10.1097/00004728-200307000-00001
pmid: 12886125
|
33 |
X Xu, C Yu, J Qu, L Zhang, S Jiang, D Huang, B Chen, Z Zhang, W Guan, Z Ling, R Jiang, T Hu, Y Ding, L Lin, Q Gan, L Luo, X Tang, J Liu. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Eur J Nucl Med Mol Imaging 2020 Feb 28. [Epub ahead of print] doi: 10.1007/s00259-020-04735-9
https://doi.org/10.1007/s00259-020-04735-9
pmid: 32107577
|
34 |
J Wu, CL Feng, XY Xian, J Qiang, J Zhang, QX Mao, SF Kong, YC Chen, JP Pan. Novel coronavirus pneumonia (COVID-19) CT distribution and sign features. Chin J Tuberc Respir Dis (Zhonghua Jie He He Hu Xi Za Zhi) 2020 Mar 3. [Epub ahead of print] (in Chinese) doi: 10.3760/cma.j.cn112147-20200217-00106
https://doi.org/10.3760/cma.j.cn112147-20200217-00106
pmid: 32125131
|
35 |
D Falzarano, E de Wit, C Martellaro, J Callison, VJ Munster, H Feldmann. Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin. Sci Rep 2013; 3(1): 1686
https://doi.org/10.1038/srep01686
pmid: 23594967
|
36 |
H Momattin, AY Al-Ali, JA Al-Tawfiq. A Systematic review of therapeutic agents for the treatment of the Middle East respiratory syndrome coronavirus (MERS-CoV). Travel Med Infect Dis 2019; 30: 9–18
https://doi.org/10.1016/j.tmaid.2019.06.012
pmid: 31252170
|
37 |
Y Shi. What are the highlights of “Diagnosis and treatment of Disease 2019 novel coronavirus infection suitable for Military support Hubei medical team”. Chin J Tuberc Respir Dis (Zhonghua Jie He He Hu Xi Za Zhi) 2020 Feb 26. [Epub ahead of print] (in Chinese) doi: 10.3760/cma.j.cn112147-20200225-00183
https://doi.org/10.3760/cma.j.cn112147-20200225-00183
pmid: 32098466
|
38 |
M Wang, R Cao, L Zhang, X Yang, J Liu, M Xu, Z Shi, Z Hu, W Zhong, G Xiao. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020; 30(3): 269–271
https://doi.org/10.1038/s41422-020-0282-0
pmid: 32020029
|
39 |
TP Sheahan, AC Sims, RL Graham, VD Menachery, LE Gralinski, JB Case, SR Leist, K Pyrc, JY Feng, I Trantcheva, R Bannister, Y Park, D Babusis, MO Clarke, RL Mackman, JE Spahn, CA Palmiotti, D Siegel, AS Ray, T Cihlar, R Jordan, MR Denison, RS Baric. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci Transl Med 2017; 9(396): eaal3653
https://doi.org/10.1126/scitranslmed.aal3653
pmid: 28659436
|
40 |
E de Wit, F Feldmann, J Cronin, R Jordan, A Okumura, T Thomas, D Scott, T Cihlar, H Feldmann. Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection. Proc Natl Acad Sci USA 2020 Feb 13. [Epub ahead of print] doi: 10.1073/pnas.1922083117
https://doi.org/10.1073/pnas.1922083117
pmid: 32054787
|
41 |
EJ Chow, JD Doyle, TM Uyeki. Influenza virus-related critical illness: prevention, diagnosis, treatment. Crit Care 2019; 23(1): 214
https://doi.org/10.1186/s13054-019-2491-9
pmid: 31189475
|
42 |
Y Shi, Y Huang, TT Zhang, B Cao, H Wang, C Zhuo, F Ye, X Su, H Fan, JF Xu, J Zhang, GX Lai, DY She, XY Zhang, B He, LX He, YN Liu, JM Qu. Chinese guidelines for the diagnosis and treatment of hospital-acquired pneumonia and ventilator-associated pneumonia in adults (2018 Edition). J Thorac Dis 2019; 11(6): 2581–2616
https://doi.org/10.21037/jtd.2019.06.09
pmid: 31372297
|
43 |
O Nishida, H Ogura, M Egi, S Fujishima, Y Hayashi, T Iba, H Imaizumi, S Inoue, Y Kakihana, J Kotani, S Kushimoto, Y Masuda, N Matsuda, A Matsushima, TA Nakada, S Nakagawa, S Nunomiya, T Sadahiro, N Shime, T Yatabe, Y Hara, K Hayashida, Y Kondo, Y Sumi, H Yasuda, K Aoyama, T Azuhata, K Doi, M Doi, N Fujimura, R Fuke, T Fukuda, K Goto, R Hasegawa, S Hashimoto, J Hatakeyama, M Hayakawa, T Hifumi, N Higashibeppu, K Hirai, T Hirose, K Ide, Y Kaizuka, T Kan’o, T Kawasaki, H Kuroda, A Matsuda, S Matsumoto, M Nagae, M Onodera, T Ohnuma, K Oshima, N Saito, S Sakamoto, M Sakuraya, M Sasano, N Sato, A Sawamura, K Shimizu, K Shirai, T Takei, M Takeuchi, K Takimoto, T Taniguchi, H Tatsumi, R Tsuruta, N Yama, K Yamakawa, C Yamashita, K Yamashita, T Yoshida, H Tanaka, S Oda. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016). Acute Med Surg 2018; 5(1): 3–89
https://doi.org/10.1002/ams2.322
pmid: 29445505
|
44 |
HY Lee, CK Rhee, JW Lee. Feasibility of high-flow nasal cannula oxygen therapy for acute respiratory failure in patients with hematologic malignancies: a retrospective single-center study. J Crit Care 2015; 30(4): 773–777
https://doi.org/10.1016/j.jcrc.2015.03.014
pmid: 25840520
|
45 |
L Dangers, C Montlahuc, A Kouatchet, S Jaber, F Meziani, S Perbet, T Similowski, M Resche-Rigon, E Azoulay, A Demoule; REVA Network (Research Network in Mechanical Ventilation) and the Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologie (GrrrOH); List of contributors who included study patients: Angers University Hospital, Angers, France. Dyspnoea in patients receiving noninvasive ventilation for acute respiratory failure: prevalence, risk factors and prognostic impact: a prospective observational study. Eur Respir J 2018; 52(2): 1702637
https://doi.org/10.1183/13993003.02637-2017
pmid: 29976650
|
46 |
E Fan, L Del Sorbo, EC Goligher, CL Hodgson, L Munshi, AJ Walkey, NKJ Adhikari, MBP Amato, R Branson, RG Brower, ND Ferguson, O Gajic, L Gattinoni, D Hess, J Mancebo, MO Meade, DF McAuley, A Pesenti, VM Ranieri, GD Rubenfeld, E Rubin, M Seckel, AS Slutsky, D Talmor, BT Thompson, H Wunsch, E Uleryk, J Brozek, LJ Brochard; American Thoracic Society, European Society of Intensive Care Medicine, and Society of Critical Care Medicine. An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical Ventilation in Adult Patients with Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 2017; 195(9): 1253–1263
https://doi.org/10.1164/rccm.201703-0548ST
pmid: 28459336
|
47 |
E Fan, D Brodie, AS Slutsky. Diagnosis and treatment in acute respiratory distress syndrome-reply. JAMA 2018; 320(3): 306
https://doi.org/10.1001/jama.2018.5932
pmid: 30027245
|
48 |
HH Yang, Y Zhou. Effect of invasive and non-invasive positive pressure ventilation on plasma brain natriuretic peptide in patients with chronic obstructive pulmonary disease and severe respiratory failure. J South Med Univ (Nan Fang Yi Ke Da Xue Xue Bao) 2010; 30(10): 2377–2379 (in Chinese)
pmid: 20965851
|
49 |
DS Hui. Severe acute respiratory syndrome (SARS): lessons learnt in Hong Kong. J Thorac Dis 2013; 5(Suppl 2): S122–S126
pmid: 23977432
|
50 |
C Ronco, P Navalesi, JL Vincent. Coronavirus epidemic: preparing for extracorporeal organ support in intensive care. Lancet Respir Med 2020; 8(3): 240–241
https://doi.org/10.1016/S2213-2600(20)30060-6
pmid: 32035509
|
51 |
Y Cheng, R Luo, K Wang, M Zhang, Z Wang, L Dong, J Li, Y Yao, Xu G Ge S,. Kidney impairment is associated with in-hospital death of COVID-19 patients. Medrxiv 2020; doi: 10.1101/2020.02.18.20023242
https://doi.org/10.1101/2020.02.18.20023242
|
52 |
K Träger, C Schütz, G Fischer, J Schröder, C Skrabal, A Liebold, H Reinelt. Cytokine reduction in the setting of an ARDS-associated inflammatory response with multiple organ failure. Case Rep Crit Care 2016; 2016: 9852073
https://doi.org/10.1155/2016/9852073
pmid: 26885411
|
53 |
J Mair-Jenkins, M Saavedra-Campos, JK Baillie, P Cleary, FM Khaw, WS Lim, S Makki, KD Rooney, JS Nguyen-Van-Tam, CR Beck; Convalescent Plasma Study Group. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis 2015; 211(1): 80–90
https://doi.org/10.1093/infdis/jiu396
pmid: 25030060
|
54 |
LJ Stockman, R Bellamy, P Garner. SARS: systematic review of treatment effects. PLoS Med 2006; 3(9): e343
https://doi.org/10.1371/journal.pmed.0030343
pmid: 16968120
|
55 |
S Mustafa, H Balkhy, MN Gabere. Current treatment options and the role of peptides as potential therapeutic components for Middle East respiratory syndrome (MERS): a review. J Infect Public Health 2018; 11(1): 9–17
https://doi.org/10.1016/j.jiph.2017.08.009
pmid: 28864360
|
56 |
PI Lee, PR Hsueh. Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV. J Microbiol Immunol Infect 2020 Feb 4. [Epub ahead of print] doi: 10.1016/j.jmii.2020.02.001
https://doi.org/10.1016/j.jmii.2020.02.001
pmid: 32035811
|
57 |
L Chen, J Xiong, L Bao, Y Shi. Convalescent plasma as a potential therapy for COVID-19. Lancet Infect Dis 2020 Feb 27. [Epub ahead of print] doi: 10.1016/S1473-3099(20)30141-9
https://doi.org/10.1016/S1473-3099(20)30141-9
pmid: 32113510
|
58 |
Y Kaneko, M Kato, Y Tanaka, M Inoo, H Kobayashi-Haraoka, K Amano, M Miyata, Y Murakawa, H Yasuoka, S Hirata, E Tanaka, N Miyasaka, H Yamanaka, K Yamamoto, T Takeuchi; SURPRISE study group. Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SURPRISE study). Ann Rheum Dis 2018; 77(9): 1268–1275
https://doi.org/10.1136/annrheumdis-2018-213416
pmid: 29853455
|
59 |
Y Kaneko, H Kameda, K Ikeda, T Ishii, K Murakami, H Takamatsu, Y Tanaka, T Abe, T Takeuchi. Tocilizumab in patients with adult-onset still’s disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial. Ann Rheum Dis 2018; 77(12): 1720–1729
https://doi.org/10.1136/annrheumdis-2018-213920
pmid: 30279267
|
60 |
JH Stone, K Tuckwell, S Dimonaco, M Klearman, M Aringer, D Blockmans, E Brouwer, MC Cid, B Dasgupta, J Rech, C Salvarani, G Schett, H Schulze-Koops, R Spiera, SH Unizony, N Collinson. Trial of tocilizumab in giant-cell arteritis. N Engl J Med 2017; 377(4): 317–328
https://doi.org/10.1056/NEJMoa1613849
pmid: 28745999
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|